Envista announces intended sale of kavo treatment unit & instrument business to planmeca

Brea, calif., sept. 7, 2021 /prnewswire/ -- envista holdings corporation (nyse: nvst) ("envista") today announced it entered into a binding agreement to sell its kavo treatment unit and instrument business to planmeca verwaltungs gmbh ("planmeca") for up to $455 million, which includes a potential earn-out payment of up to $30 million.
NVST Ratings Summary
NVST Quant Ranking